Biostate

BIOLOGICAL4 trials

Sponsors

CSL Behring

Conditions

Hemophilia AVon Willebrand Disease

Phase 3

Study of Biostate® in Children With Von Willebrand Disease

CompletedNCT01213446

CSL BehringVon Willebrand Disease

Start: 2010-08-31End: 2013-08-31Updated: 2017-10-03

Extension Study of Biostate in Subjects With Von Willebrand Disease

CompletedNCT01224808

CSL BehringVon Willebrand Disease

Start: 2010-10-31End: 2014-03-31Updated: 2017-10-03

Study of Biostate® in Children With Hemophilia A

CompletedNCT01229007

CSL BehringHemophilia A

Start: 2010-08-31End: 2014-07-31Updated: 2017-08-24

Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

TerminatedNCT01445197

CSL BehringHemophilia A

Start: 2012-12-31End: 2013-12-31Updated: 2017-10-03

Related Papers

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study).

2021-06-212 citations